Stocktoria
Jade Biosciences, Inc. JBIO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-06-30
Jade Biosciences, Inc. statistics & valuation
Market cap$1.3B
P / B4.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -36.4% | -95.6% | -59.3% | -38.1% | -13.1% |
| Return on equity | -38.3% | 148.8% | -69.0% | -40.6% | -13.3% |
| Current ratio | 21.09 | 5.81 | 7.04 | 16.90 | 68.37 |
Source: SEC EDGAR filings · CIK 0001798749 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.